370864-72-5 Usage
General Description
3-(Piperidin-4-yl)benzonitrile is a chemical compound that consists of a benzene ring linked to a piperidine ring and a nitrile group. It is commonly used as an intermediate in the production of pharmaceuticals and agrochemicals, as well as in organic synthesis. 3-(Piperidin-4-yl)benzonitrile is known to possess sedative and analgesic properties, and has been studied for its potential applications in the treatment of various central nervous system disorders. In addition, it has been investigated as a building block for the synthesis of diverse heterocyclic compounds with potential biological activities. However, it is important to handle this compound with caution as it may pose potential health and environmental hazards if not managed properly.
Check Digit Verification of cas no
The CAS Registry Mumber 370864-72-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,0,8,6 and 4 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 370864-72:
(8*3)+(7*7)+(6*0)+(5*8)+(4*6)+(3*4)+(2*7)+(1*2)=165
165 % 10 = 5
So 370864-72-5 is a valid CAS Registry Number.
370864-72-5Relevant articles and documents
BENZOXAZINYL-AMIDOCYCLOPENTYL-HETEROCYCLIC MODULATORS OF CHEMOKINE RECEPTORS
-
, (2010/11/28)
Cyclopentyl compounds linked to a benzoxazinyl group through an amido moiety utilizing the ring nitrogen of the benzoxazine, and further substituted with a heterocyclic moiety, such compounds represented by formula I: which are used to modulate the CCR-2 chemokine receptor to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis; and pharmaceutical compositions comprising these compounds and the use of these compounds and compositions.
1-aroyl-piperidinyl benzamidines
-
, (2008/06/13)
This invention relates to compounds of formula which inhibit Factor Xa or tryptase, to pharmaceutical compositions containing the compounds, and to the use of the compounds for the treatment of patients suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa or tryptase.
